ArticleFrontiers in oncology2024

The impact of Bruton's tyrosine kinase inhibitor treatment on COVID-19 outcomes in Chinese patients with chronic lymphocytic leukemia.

Shenmiao Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.